Suppression of Resting Metabolism by the Angiotensin AT2 Receptor

Cell Reports

Volumn 16, Issue 6, 2016, Pages 1548-1560

  Littlejohn, Nicole K ^a   Keen, Henry L ^a   Weidemann, Benjamin J ^a   Claflin, Kristin E ^a   Tobin, Kevin V ^a   Markan, Kathleen R ^a   Park, Sungmi ^a   Naber, Meghan C ^a   Gourronc, Francoise A ^b   Pearson, Nicole A ^a   Liu, Xuebo ^a   Morgan, Donald A ^a   Klingelhutz, Aloysius J ^a,b   Potthoff, Matthew J ^a,b   Rahmouni, Kamal ^a,b   Sigmund, Curt D ^a,b   Grobe, Justin L ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; SYNAPSIN; UNCOUPLING PROTEIN 1; ANGIOTENSIN II;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BODY FAT DISTRIBUTION; BODY TEMPERATURE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL METABOLISM; CELL RESPIRATION; CONTROLLED STUDY; CORE TEMPERATURE; ENERGY EXPENDITURE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESTING METABOLIC RATE; SIGNAL TRANSDUCTION; THERMOGENESIS; ANIMAL; BRAIN; C57BL MOUSE; ENERGY METABOLISM; METABOLISM; OBESITY; PHYSIOLOGY; WHITE ADIPOSE TISSUE;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; ANGIOTENSIN II; ANIMALS; BRAIN; ENERGY METABOLISM; MICE, INBRED C57BL; OBESITY; RECEPTOR, ANGIOTENSIN, TYPE 2; RENIN-ANGIOTENSIN SYSTEM;

EID: 84979752805     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2016.07.003     Document Type: Article

References (76)

1. Abate, N., Garg, A., Peshock, R.M., Stray-Gundersen, J., Grundy, S.M., Relationships of generalized and regional adiposity to insulin sensitivity in men. J. Clin. Invest. 96 (1995), 88–98.
2. Atgié, C., D'Allaire, F., Bukowiecki, L.J., Role of beta1- and beta3-adrenoceptors in the regulation of lipolysis and thermogenesis in rat brown adipocytes. Am. J. Physiol. 273 (1997), C1136–C1142.
3. Blaak, E., Gender differences in fat metabolism. Curr. Opin. Clin. Nutr. Metab. Care 4 (2001), 499–502.
4. Bordicchia, M., Liu, D., Amri, E.-Z., Ailhaud, G., Dessì-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R., Collins, S., Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J. Clin. Invest. 122 (2012), 1022–1036.
5. Bottari, S.P., King, I.N., Reichlin, S., Dahlstroem, I., Lydon, N., de Gasparo, M., The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase. Biochem. Biophys. Res. Commun. 183 (1992), 206–211.
6. Burnett, C.M., Grobe, J.L., Direct calorimetry identifies deficiencies in respirometry for the determination of resting metabolic rate in C57Bl/6 and FVB mice. Am. J. Physiol. Endocrinol. Metab. 305 (2013), E916–E924.
7. Claflin, K.E., Grobe, J.L., Control of energy balance by the brain renin-angiotensin system. Curr. Hypertens. Rep., 17, 2015, 38.
8. de Kloet, A.D., Krause, E.G., Woods, S.C., The renin angiotensin system and the metabolic syndrome. Physiol. Behav. 100 (2010), 525–534.
9. de Kloet, A.D., Krause, E.G., Scott, K.A., Foster, M.T., Herman, J.P., Sakai, R.R., Seeley, R.J., Woods, S.C., Central angiotensin II has catabolic action at white and brown adipose tissue. Am. J. Physiol. Endocrinol. Metab. 301 (2011), E1081–E1091.
10. de Kloet, A.D., Pati, D., Wang, L., Hiller, H., Sumners, C., Frazier, C.J., Seeley, R.J., Herman, J.P., Woods, S.C., Krause, E.G., Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus protect against diet-induced obesity. J. Neurosci. 33 (2013), 4825–4833.
11. Engeli, S., Böhnke, J., Gorzelniak, K., Janke, J., Schling, P., Bader, M., Luft, F.C., Sharma, A.M., Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45 (2005), 356–362.
12. Feng, J., Meyer, C.A., Wang, Q., Liu, J.S., Shirley Liu, X., Zhang, Y., GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data. Bioinformatics 28 (2012), 2782–2788.
13. Fischer, B., Schöttl, T., Schempp, C., Fromme, T., Hauner, H., Klingenspor, M., Skurk, T., Inverse relationship between body mass index and mitochondrial oxidative phosphorylation capacity in human subcutaneous adipocytes. Am. J. Physiol. Endocrinol. Metab. 309 (2015), E380–E387.
14. Gadupudi, G., Gourronc, F.A., Ludewig, G., Robertson, L.W., Klingelhutz, A.J., PCB126 inhibits adipogenesis of human preadipocytes. Toxicol. In Vitro 29 (2015), 132–141.
15. Gao, L., Zucker, I.H., AT2 receptor signaling and sympathetic regulation. Curr. Opin. Pharmacol. 11 (2011), 124–130.
16. Goossens, G.H., Blaak, E.E., van Baak, M.A., Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes. Rev. 4 (2003), 43–55.
17. Grassi, G., Seravalle, G., Dell'Oro, R., Trevano, F.Q., Bombelli, M., Scopelliti, F., Facchini, A., Mancia, G., Study, C., CROSS Study. Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. J. Hypertens. 21 (2003), 1761–1769.
18. Grobe, J.L., Grobe, C.L., Beltz, T.G., Westphal, S.G., Morgan, D.A., Xu, D., de Lange, W.J., Li, H., Sakai, K., Thedens, D.R., et al. The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab. 12 (2010), 431–442.
19. Grobe, J.L., Buehrer, B.A., Hilzendeger, A.M., Liu, X., Davis, D.R., Xu, D., Sigmund, C.D., Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice. Hypertension 57 (2011), 600–607.
20. Grobe, J.L., Rahmouni, K., Liu, X., Sigmund, C.D., Metabolic rate regulation by the renin-angiotensin system: brain vs. body. Pflugers Arch. 465 (2013), 167–175.
21. Gross, V., Milia, A.F., Plehm, R., Inagami, T., Luft, F.C., Long-term blood pressure telemetry in AT2 receptor-disrupted mice. J. Hypertens. 18 (2000), 955–961.
22. Gustafson, D.R., Karlsson, C., Skoog, I., Rosengren, L., Lissner, L., Blennow, K., Mid-life adiposity factors relate to blood-brain barrier integrity in late life. J. Intern. Med. 262 (2007), 643–650.
23. Hauner, H., Röhrig, K., Petruschke, T., Effects of epidermal growth factor (EGF), platelet-derived growth factor (PDGF) and fibroblast growth factor (FGF) on human adipocyte development and function. Eur. J. Clin. Invest. 25 (1995), 90–96.
24. Hein, L., Barsh, G.S., Pratt, R.E., Dzau, V.J., Kobilka, B.K., Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377 (1995), 744–747.
25. Hilzendeger, A.M., Cassell, M.D., Davis, D.R., Stauss, H.M., Mark, A.L., Grobe, J.L., Sigmund, C.D., Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension. Hypertension 61 (2013), 716–722.
26. Hines, J., Heerding, J.N., Fluharty, S.J., Yee, D.K., Identification of angiotensin II type 2 (AT2) receptor domains mediating high-affinity CGP 42112A binding and receptor activation. J. Pharmacol. Exp. Ther. 298 (2001), 665–673.
27. Hsueh, W., Davidai, G., Henry, R., Mudaliar, S., Telmisartan effects on insulin resistance in obese or overweight adults without diabetes or hypertension. J. Clin. Hypertens. (Greenwich) 12 (2010), 746–752.
28. Kazak, L., Chouchani, E.T., Jedrychowski, M.P., Erickson, B.K., Shinoda, K., Cohen, P., Vetrivelan, R., Lu, G.Z., Laznik-Bogoslavski, D., Hasenfuss, S.C., et al. A creatine-driven substrate cycle enhances energy expenditure and thermogenesis in beige fat. Cell 163 (2015), 643–655.
29. Kohno, M., Horio, T., Yokokawa, K., Murakawa, K., Yasunari, K., Akioka, K., Tahara, A., Toda, I., Takeuchi, K., Kurihara, N., et al. Brain natriuretic peptide as a cardiac hormone in essential hypertension. Am. J. Med. 92 (1992), 29–34.
30. Krotkiewski, M., Björntorp, P., Sjöström, L., Smith, U., Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J. Clin. Invest. 72 (1983), 1150–1162.
31. Langmead, B., Trapnell, C., Pop, M., Salzberg, S.L., Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol., 10, 2009, R25.
32. Lee, J.S., Suh, J.M., Park, H.G., Bak, E.J., Yoo, Y.J., Cha, J.H., Heparin-binding epidermal growth factor-like growth factor inhibits adipocyte differentiation at commitment and early induction stages. Differentiation 76 (2008), 478–487.
33. Lee, K.M., Nam, K., Oh, S., Lim, J., Lee, T., Shin, I., ECM1 promotes the Warburg effect through EGF-mediated activation of PKM2. Cell. Signal. 27 (2015), 228–235.
34. Lindholm, L.H., Persson, M., Alaupovic, P., Carlberg, B., Svensson, A., Samuelsson, O., Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study). J. Hypertens. 21 (2003), 1563–1574.
35. Littlejohn, N.K., Grobe, J.L., Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309 (2015), R1463–R1473.
36. Littlejohn, N.K., Siel, R.B. Jr., Ketsawatsomkron, P., Pelham, C.J., Pearson, N.A., Hilzendeger, A.M., Buehrer, B.A., Weidemann, B.J., Li, H., Davis, D.R., et al. Hypertension in mice with transgenic activation of the brain renin-angiotensin system is vasopressin dependent. Am. J. Physiol. Regul. Integr. Comp. Physiol. 304 (2013), R818–R828.
37. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 (2001), 402–408.
38. Markan, K.R., Naber, M.C., Ameka, M.K., Anderegg, M.D., Mangelsdorf, D.J., Kliewer, S.A., Mohammadi, M., Potthoff, M.J., Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes 63 (2014), 4057–4063.
39. McLaughlin, T., Lamendola, C., Liu, A., Abbasi, F., Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J. Clin. Endocrinol. Metab. 96 (2011), E1756–E1760.
40. Meffert, S., Stoll, M., Steckelings, U.M., Bottari, S.P., Unger, T., The angiotensin II AT2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol. Cell. Endocrinol. 122 (1996), 59–67.
41. Miyazaki, Y., DeFronzo, R.A., Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type. Cardiovasc. Diabetol., 8, 2009, 44.
42. Nag, S., Khan, M.A., Samuel, P., Ali, Q., Hussain, T., Chronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen. Metabolism 64 (2015), 814–825.
43. National Research Council. Guide for the Care and Use of Laboratory Animals. 2011, National Academies Press.
44. Nedergaard, J., Cannon, B., UCP1 mRNA does not produce heat. Biochim. Biophys. Acta 1831 (2013), 943–949.
45. Nouet, S., Amzallag, N., Li, J.M., Louis, S., Seitz, I., Cui, T.X., Alleaume, A.M., Di Benedetto, M., Boden, C., Masson, M., et al. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J. Biol. Chem. 279 (2004), 28989–28997.
46. Pedersen, S.B., Kristensen, K., Bruun, J.M., Flyvbjerg, A., Vinter-Jensen, L., Richelsen, B., Systemic administration of epidermal growth factor increases UCP3 mRNA levels in skeletal muscle and adipose tissue in rats. Biochem. Biophys. Res. Commun. 279 (2000), 914–919.
47. Plouffe, B., Guimond, M.O., Beaudry, H., Gallo-Payet, N., Role of tyrosine kinase receptors in angiotensin II AT2 receptor signaling: involvement in neurite outgrowth and in p42/p44mapk activation in NG108-15 cells. Endocrinology 147 (2006), 4646–4654.
48. Porter, J.P., Potratz, K.R., Effect of intracerebroventricular angiotensin II on body weight and food intake in adult rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287 (2004), R422–R428.
49. Porter, J.P., Anderson, J.M., Robison, R.J., Phillips, A.C., Effect of central angiotensin II on body weight gain in young rats. Brain Res. 959 (2003), 20–28.
50. Rahmouni, K., Fath, M.A., Seo, S., Thedens, D.R., Berry, C.J., Weiss, R., Nishimura, D.Y., Sheffield, V.C., Leptin resistance contributes to obesity and hypertension in mouse models of Bardet-Biedl syndrome. J. Clin. Invest. 118 (2008), 1458–1467.
51. Rim, J.S., Kozak, L.P., Regulatory motifs for CREB-binding protein and Nfe2l2 transcription factors in the upstream enhancer of the mitochondrial uncoupling protein 1 gene. J. Biol. Chem. 277 (2002), 34589–34600.
52. Robinson, M.D., McCarthy, D.J., Smyth, G.K., edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26 (2010), 139–140.
53. Sagnella, G.A., Markandu, N.D., Shore, A.C., MacGregor, G.A., Raised circulating levels of atrial natriuretic peptides in essential hypertension. Lancet 1 (1986), 179–181.
54. Sakai, K., Agassandian, K., Morimoto, S., Sinnayah, P., Cassell, M.D., Davisson, R.L., Sigmund, C.D., Local production of angiotensin II in the subfornical organ causes elevated drinking. J. Clin. Invest. 117 (2007), 1088–1095.
55. Samuel, P., Khan, M.A., Nag, S., Inagami, T., Hussain, T., Angiotensin AT(2) receptor contributes towards gender bias in weight gain. PLoS ONE, 8, 2013, e48425.
56. Serrero, G., EGF inhibits the differentiation of adipocyte precursors in primary cultures. Biochem. Biophys. Res. Commun. 146 (1987), 194–202.
57. Serrero, G., Mills, D., Physiological role of epidermal growth factor on adipose tissue development in vivo. Proc. Natl. Acad. Sci. USA 88 (1991), 3912–3916.
58. Shabalina, I.G., Petrovic, N., de Jong, J.M., Kalinovich, A.V., Cannon, B., Nedergaard, J., UCP1 in brite/beige adipose tissue mitochondria is functionally thermogenic. Cell Rep. 5 (2013), 1196–1203.
59. Shenoy, U.V., Richards, E.M., Huang, X.C., Sumners, C., Angiotensin II type 2 receptor-mediated apoptosis of cultured neurons from newborn rat brain. Endocrinology 140 (1999), 500–509.
60. Shimabukuro, M., Tanaka, H., Shimabukuro, T., Effects of telmisartan on fat distribution in individuals with the metabolic syndrome. J. Hypertens. 25 (2007), 841–848.
61. Storey, J.D., Tibshirani, R., Statistical significance for genomewide studies. Proc. Natl. Acad. Sci. USA 100 (2003), 9440–9445.
62. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102 (2005), 15545–15550.
63. Swingle, M., Ni, L., Honkanen, R.E., Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse. Methods Mol. Biol. 365 (2007), 23–38.
64. Velpula, K.K., Bhasin, A., Asuthkar, S., Tsung, A.J., Combined targeting of PDK1 and EGFR triggers regression of glioblastoma by reversing the Warburg effect. Cancer Res. 73 (2013), 7277–7289.
65. Vidal-Puig, A., Solanes, G., Grujic, D., Flier, J.S., Lowell, B.B., UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue. Biochem. Biophys. Res. Commun. 235 (1997), 79–82.
66. Vu, B.G., Gourronc, F.A., Bernlohr, D.A., Schlievert, P.M., Klingelhutz, A.J., Staphylococcal superantigens stimulate immortalized human adipocytes to produce chemokines. PLoS ONE, 8, 2013, e77988.
67. Vu, B.G., Stach, C.S., Kulhankova, K., Salgado-Pabón, W., Klingelhutz, A.J., Schlievert, P.M., Chronic superantigen exposure induces systemic inflammation, elevated bloodstream endotoxin, and abnormal glucose tolerance in rabbits: possible role in diabetes. MBio, 6, 2015, e02554.
68. Wagner, B.A., Venkataraman, S., Buettner, G.R., The rate of oxygen utilization by cells. Free Radic. Biol. Med. 51 (2011), 700–712.
69. Watanabe, T., Hashimoto, M., Okuyama, S., Inagami, T., Nakamura, S., Effects of targeted disruption of the mouse angiotensin II type 2 receptor gene on stress-induced hyperthermia. J. Physiol. 515 (1999), 881–885.
70. Wu, J., Boström, P., Sparks, L.M., Ye, L., Choi, J.H., Giang, A.H., Khandekar, M., Virtanen, K.A., Nuutila, P., Schaart, G., et al. Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 150 (2012), 366–376.
71. Yasue, S., Masuzaki, H., Okada, S., Ishii, T., Kozuka, C., Tanaka, T., Fujikura, J., Ebihara, K., Hosoda, K., Katsurada, A., et al. Adipose tissue-specific regulation of angiotensinogen in obese humans and mice: impact of nutritional status and adipocyte hypertrophy. Am. J. Hypertens. 23 (2010), 425–431.
72. Yiannikouris, F., Gupte, M., Putnam, K., Thatcher, S., Charnigo, R., Rateri, D.L., Daugherty, A., Cassis, L.A., Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice. Hypertension 60 (2012), 1524–1530.
73. Yiannikouris, F., Karounos, M., Charnigo, R., English, V.L., Rateri, D.L., Daugherty, A., Cassis, L.A., Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 302 (2012), R244–R251.
74. Yvan-Charvet, L., Quignard-Boulangé, A., Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int. 79 (2011), 162–168.
75. Yvan-Charvet, L., Even, P., Bloch-Faure, M., Guerre-Millo, M., Moustaid-Moussa, N., Ferre, P., Quignard-Boulange, A., Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54 (2005), 991–999.
76. Yvan-Charvet, L., Massiéra, F., Lamandé, N., Ailhaud, G., Teboul, M., Moustaid-Moussa, N., Gasc, J.M., Quignard-Boulangé, A., Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue. Endocrinology 150 (2009), 1421–1428.